For research use only. Not for therapeutic Use.
STC-15 (example 70) is an orally active METTL3 inhibitor used in the study of proliferative diseases such as cancer and autoimmune diseases[1].
| Catalog Number | I040767 |
| CAS Number | 2648257-56-9 |
| Synonyms | N-[[2-[(cyclobutylmethylamino)methyl]-1H-indol-6-yl]methyl]-4-oxopyrido[1,2-a]pyrimidine-2-carboxamide |
| Molecular Formula | C24H25N5O2 |
| Purity | ≥95% |
| InChI | InChI=1S/C24H25N5O2/c30-23-12-21(28-22-6-1-2-9-29(22)23)24(31)26-14-17-7-8-18-11-19(27-20(18)10-17)15-25-13-16-4-3-5-16/h1-2,6-12,16,25,27H,3-5,13-15H2,(H,26,31) |
| InChIKey | MFQFZLWCFZZHAI-UHFFFAOYSA-N |
| SMILES | C1CC(C1)CNCC2=CC3=C(N2)C=C(C=C3)CNC(=O)C4=CC(=O)N5C=CC=CC5=N4 |
| Reference | [1]. Wesley Peter Blackaby, et al. Polyheterocyclic compounds as mettl3 inhibitors. Patent WO2021111124A1. |
